Navigation Links
Tigris Pharmaceuticals Signs CRADA with the National Cancer Institute
Date:5/15/2008

BONITA SPRINGS, Fla., May 15 /PRNewswire/ -- Tigris Pharmaceuticals, Inc. announced today the execution of a Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute (NCI) to collaborate on clinical and preclinical development of AFP-464, an aminoflavone currently in Phase I development. AFP-464 is converted to metabolites which bind covalently to DNA, resulting in p53 activation and apoptosis.

This is part of a four-year CRADA encompassing multiple Phase I and Phase II clinical studies with correlating translational research of AFP-464 in a variety of tumor types. The goal of this research collaboration is to work together for the successful development of AFP-464 as a safe and effective novel pharmaceutical compound for the treatment of cancer. Under this CRADA, two Phase I studies with AFP-464 are currently enrolling in the United States, sponsored by the NCI, at the Mayo Clinic, Wayne State University, and the University of Maryland. These studies are evaluating AFP-464 in patients with advanced solid tumors. Tigris has also initiated a Phase I program at leading cancer research centers in Belgium and France; this work is not included in the CRADA research. The AFP-464 program is anticipated to move to Phase II development in 2009.

"It will be a privilege to work with the NCI on such a promising therapeutic for patients with cancer," stated Edmundo Muniz, M.D., Ph.D., Chief Executive Officer of Tigris. "This CRADA further solidifies the successful partnership to date between Tigris and the NCI."

About AFP-464

Preclinical studies into AFP-464's mechanism of action have shown that AFP-464 induces CYP1A1/1A2 and CYP1B1 protein expression and is converted to metabolites that are covalently bound to DNA, resulting in phosphorylation of p53 with induction of the p53 downstream target p21(Waf1/Cip1) and apoptosis. AFP-464 has shown a unique pattern of growth inhibitory activity in the NCI's 60 tumor ce
'/>"/>

SOURCE Tigris Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors
2. VIA Pharmaceuticals Completes Enrollment in Phase 2 Acute Coronary Syndrome (ACS) Trial
3. Poniard Pharmaceuticals Licenses Kinase Inhibitors From The Scripps Research Institute
4. Alseres Pharmaceuticals Announces 12 Month Interim Results from the Phase I/IIa Cethrin(R) Clinical Trial in Acute Spinal Cord Injury
5. Vion Pharmaceuticals Announces Initiation of Clinical Trial of Cloretazine(R) (VNP40101M) in Combination with Cytarabine
6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
7. Poniard Pharmaceuticals Completes Enrollment of Phase 2 Picoplatin Trial in Colorectal Cancer
8. Cadence Pharmaceuticals Reports First Quarter 2008 Financial Results and Provides Clinical Program Update
9. Alseres Pharmaceuticals Enters Agreement to Amend Cethrin(R) License to Lower Milestone Payments and Royalty Rates
10. Champions Biotechnology and Concordia Pharmaceuticals Complete Service Agreement and Begin Preclinical Evaluation of Oncology Drugs
11. Amylin Pharmaceuticals Initiates Phase 2B Dose-Ranging Clinical Study of Pramlintide/Metreleptin Combination Treatment in Obesity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2014)... DALLAS , September 12, 2014 ... Cans Market by Application [Beverages (Alcoholic, CSD, Sports & ... Food, Pet Food, Meat & Seafood)], by Material ... published by MarketsandMarkets, defines and segments the Food ... projections of each application in terms of volumes ...
(Date:9/12/2014)... , Sept. 12, 2014  Royal Philips (NYSE: ... number of innovations at ASTRO,s 56th Annual Meeting ... solutions that increase workflow automation, confidence, consistency and accuracy ... and enhancing patient-centric care, these radiation oncology solutions underscore ... a more personalized approach to medicine. "Philips ...
(Date:9/12/2014)... DUBLIN , Sept. 12, 2014 Research ... Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast - ... cancer is the most common cancer among women in both ... was in double digit Billion US$ for 2013. ... cancer screening globally. China is expected ...
Breaking Medicine Technology:Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 2Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 3Food & Beverage Metal Cans Market Worth $49.20 Billion by 2019 4Philips Demonstrates Commitment to Radiation Oncology Solutions at ASTRO 2014 2Philips Demonstrates Commitment to Radiation Oncology Solutions at ASTRO 2014 3Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast - Worldwide 2Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast - Worldwide 3Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast - Worldwide 4
... March 7, 2011 Ajinomoto Co., a leader ... safe, effective nutraceutical solutions, has announced that its ... federal trademark registration, (®), on the Principal Register ...  The trademark is the latest milestone for Capsiate ...
... 7, 2011 HGI Global Holdings, Inc., a leading ... today announced the appointment of Michael B. Petras, Jr. ... Mr. Petras, 43, joins HGI from GE Lighting, ... (NYSE: GE ) where he served as ...
Cached Medicine Technology:Ajinomoto Co.'s Capsiate Natura® Reaches New Milestone 2Michael Petras, Former CEO of GE Lighting, Named CEO of Cleveland-Based Specialty Medical Supplies Leader 2Michael Petras, Former CEO of GE Lighting, Named CEO of Cleveland-Based Specialty Medical Supplies Leader 3
(Date:9/13/2014)... Over the past five years, ... Australia have shown signs of struggle. “The ... goods has caused Australian consumers to turn away ... IBISWorld industry analyst Ryan Lin. This trend has ... health consciousness, which has alerted the Australian population ...
(Date:9/13/2014)... MillionaireSinglesDating.com is a millionaire dating site ... dating services provider, which also launched the leading ... daddy site , SugarDaddyMeet.com, and the leading ... recently reached 2 million users milestone. , MillionaireSinglesDating.com ... include CEOs, lawyers, doctors, pro athletes, models and ...
(Date:9/13/2014)... Hills, CA (PRWEB) September 13, 2014 Bedros ... and renowned fitness marketing coach , has always been ... people think Groupon’s most useful days are over, but the ... using it may need to change. , “A lot of ... some quick income,” says Keuilian. “They run a special and ...
(Date:9/13/2014)... Happiness is a choice that can transform lives ... That's what LWell believes thanks to Joana U-Ming ... life coach who has loved fitness and has been practicing ... "Happiness is a Choice" seminar at its Yorktown, Va. location ... event is being offered free as a gift to the ...
(Date:9/13/2014)... The number of retail customers estimated to have ... is staggering, just look at some of the big names ... The New York Times, with Target and Home Dept alone ... current pace of these huge retailer data breaches continues to ... can it really be before every consumer in America finds ...
Breaking Medicine News(10 mins):Health News:Confectionery Manufacturing in Australia Industry Market Research Report Now Available from IBISWorld 2Health News:Confectionery Manufacturing in Australia Industry Market Research Report Now Available from IBISWorld 3Health News:MillionaireSinglesDating.com Reaches 2 Million Users Milestone 2Health News:Renegade Fitness Marketing Expert Reveals How Personal Trainers Can Use Groupon More Effectively to Sign New Clients 2Health News:Renegade Fitness Marketing Expert Reveals How Personal Trainers Can Use Groupon More Effectively to Sign New Clients 3Health News:“Happiness is a Choice” Life Coaching Seminar Open to Community 2Health News:“Happiness is a Choice” Life Coaching Seminar Open to Community 3Health News:Hacking Whales of the Retail World Can Start With Just One Little Phish 2Health News:Hacking Whales of the Retail World Can Start With Just One Little Phish 3Health News:Hacking Whales of the Retail World Can Start With Just One Little Phish 4Health News:Hacking Whales of the Retail World Can Start With Just One Little Phish 5
... Drugs that Facilitate and/or Prevent Diabetes//. ... develop new-onset diabetes than those who don’t have hypertension, ... recent weight gain, or stronger family history of diabetes ... have known since 1958 that some drugs used to ...
... to tell their partners// to seek treatment and, in ... help reduce infection rates, says a new study on ... of managing most curable sexually transmitted infections, but the ... difficult. ,Researchers analysed 14 studies involving ...
... The All India Institute of Medical Sciences (AIIMS) Friday become ... the most advanced four-arm robot - Da Vinci S. ... in July last year and today we completed the 100th ... in Asia," said Ashok K. Hemal, a senior professor at ...
... Wake Forest University Baptist Medical Center are helping to ... sites that will test 3,000 patients in an effort ... failure patients. ,Though doctors have promoted the value ... “exercise training has not been definitively established as safe ...
... to save the day during life-threatening allergic reactions// and ... amongst medics. ,Wellington-based Mayne Pharma, New ... German manufacturers. This has led to the interruption in ... ,Hospitals in New Zealand, hope to tide over this ...
... Edmonton’s Capital Health Region.// As per this, information on blood ... she visits a hospital, clinic or a doctor which is ... be used to detect diabetes and treat the illness if ... manifest itself as blindness, kidney failure, amputation of limbs etc. ...
Cached Medicine News:Health News:Differences Between BP Medicines and Newly-Diagnosed Diabetes Identified 2Health News:Differences Between BP Medicines and Newly-Diagnosed Diabetes Identified 3Health News:New International Study to Test Exercise in Heart Failure Patients 2Health News:New International Study to Test Exercise in Heart Failure Patients 3
... The 5mm AEM Laparoscopic Instruments incorporate ... AEM Instruments are shielded and monitored to ... of the instrument caused by insulation failure ... risk. The protective shield built into all ...
... incorporate a layered design unique in the ... to prevent stray electrosurgical burns along the ... failure or capacitive coupling; a well-documented patient ... all AEM Instruments provides a neutral return ...
... incorporate a layered design unique in the ... to prevent stray electrosurgical burns along the ... failure or capacitive coupling; a well-documented patient ... all AEM Instruments provides a neutral return ...
... The 5mm AEM Laparoscopic Instruments incorporate a ... Instruments are shielded and monitored to prevent ... the instrument caused by insulation failure or ... The protective shield built into all AEM ...
Medicine Products: